文献速递甲状腺疾病

转移性甲状腺癌患者循环肿瘤细胞的检测及其预后意义

Detection and Prognostic Significance of Circulating Tumor Cells in Patients With Metastatic Thyroid Cancer.
PubMed 文献 · J Clin Endocrinol Metab · 2016-08-30

这项前瞻性研究在三级癌症医院开展,用Veridex CellSearch检测18例远处转移性甲状腺髓样癌(metMTC)、14例远处转移性分化型甲状腺癌(metDTC)及10例无病对照者的循环肿瘤细胞(CTC)。6例metMTC患者CTC≥5个,metDTC及对照均未检出≥5个;metMTC中CTC≥5个者中位生存13个月,<5个者51.5个月(P=0.0116),死亡HR 3.95(1.20-13.0,P=0.0245)。作者认为CTC≥5个与更差总生存相关,需更大队列验证。

要点

  • metMTC患者中6例检出CTC≥5个,metDTC和对照均无CTC≥5个。
  • metMTC中CTC≥5个者中位生存13个月,<5个者51.5个月(P=0.0116)。
  • CTC≥5个者死亡HR 3.95(1.20-13.0,P=0.0245),作者认为与更差OS相关。

核心结论

  • metMTC患者CTC≥5个与更差总生存相关。
  • 作者指出需更大队列验证CTC计数的预后价值。

研究设计与样本

  • 前瞻性研究,在三级癌症医院开展。
  • 先用甲状腺癌细胞系评估Veridex CellSearch检测可行性,再检测18例metMTC、14例metDTC和10例无病对照者的血样。
  • 评估metMTC患者CTC水平预测总生存的预后价值。

主要发现

  • CellSearch可检出MTC和DTC细胞系,未检出未分化甲状腺癌细胞系。
  • 6例metMTC患者CTC≥5个,metDTC和对照均无CTC≥5个。
  • metMTC中CTC≥5个者中位生存13个月,<5个者51.5个月(P=0.0116)。
  • metMTC中CTC≥5个者较<5个者死亡HR 3.95(1.20-13.0,P=0.0245)。

临床怎么用

  • 作者认为metMTC患者CTC≥5个与更差总生存相关,并指出需更大队列验证CTC计数的预后价值。

局限性

  • 作者指出需更大队列验证CTC计数的预后价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Individual patient prognostication for advanced thyroid cancer (TC) is challenging. Circulating tumor cells (CTCs) have been shown to be a valuable prognostic marker for other solid cancers. OBJECTIVE: We hypothesized that CTCs are present in the blood of patients with advanced TC and their number can predict overall survival (OS). SETTING: This is a prospective study at a tertiary cancer hospital. Patients, Interventions, and Main Outcome Measures: Initial studies were performed with TC cell lines to determine the feasibility of detection using the Veridex CellSearch. CTC enumeration was performed in blood samples from 18 patients with distantly metastatic medullary TC (metMTC), 14 with distantly metastatic differentiated TC (metDTC), and 10 controls with a history of TC but no evidence of disease. The prognostic value of CTC levels to predict OS in metMTC patients was assessed. RESULTS: CellSearch detected cells from MTC and DTC but not anaplastic TC cell lines. Six metMTC patients but no metDTC or control patients had more than or equal to 5 CTCs detected by the CellSearch assay. Median survival in metMTC patients with more than or equal to 5 CTCs was 13 months vs 51.5 months for those with less than 5 CTCs (P = .0116). The hazard ratio for mortality of patients with more than or equal to 5 CTCs compared with those with less than 5 CTCs was 3.95 (1.20-13.0, P = .0245). CONCLUSIONS: The presence of more than or equal to 5 CTCs in patients with metMTC is associated with worse OS. Larger cohorts are required to validate the prognostic value of CTC enumeration.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Xu JY, Handy B, Michaelis CL, et al. Detection and Prognostic Significance of Circulating Tumor Cells in Patients With Metastatic Thyroid Cancer. J Clin Endocrinol Metab. 2016. PMID: 27575943

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。